Referred to as the "Comfort Cryonics Castle," it was once intended to store human organs and bodies for the "Timeship" ...

Researchers from the Flanders Institute of Biotechnology (VIB) and the University of Antwerp have discovered a key genetic risk factor for a rare form of frontotemporal dementia (LVD) that develops in ...

A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...

Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

Biotech investments fuel DNA manufacturing in Asia-Pacific. The global DNA manufacturing market is projected to reach $21.82b ...

Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic ...

Inovio Pharmaceuticals has laid off staff and prioritized programs to focus on its lead rare disease candidate, which is ...

Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...

Dr Singh highlighted India’s unique advantage in genomic research due to its large and genetically diverse population.

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...